Latest Asx Filings News

Premier1 Lithium reports its first inferred gold Mineral Resource at Wadgingarra and a new high-grade gold discovery at Rochefort, alongside a $1.84 million entitlement offer to fund exploration.

Castle Minerals has completed a strategic acquisition to expand its Côte d’Ivoire footprint while reporting promising gold drill results in Ghana, supported by a strengthened Board and fresh capital.

Reedy Lagoon Corporation is gearing up for initial drilling at its Burracoppin Gold Project while actively seeking a joint venture partner for its Burracoppin Iron Project, maintaining a cautious cash position of just under $80,000.

Venari Minerals has launched RC drilling at its Red Mountain Lithium Project aiming for a maiden resource by year-end, while Needles Gold Project drilling confirms promising gold-silver targets. A $5.5 million placement strengthens its exploration funding.

Riversgold has secured a full funding and operational partnership with MEGA Resources for its Northern Zone Gold Project near Kalgoorlie, while also farming out its Saint John project in Canada to AIS Resources. The company raised A$1.8 million to advance exploration and development.

Acrux Limited reports robust revenue growth in Q1 FY26, driven by strong profit share income from recently launched topical pharmaceuticals and a significant R&D tax rebate repayment.

Northern Minerals Limited reported a net operating cash outflow of AUD 6.61 million for Q3 2025, ending the quarter with AUD 17.48 million in cash and equivalents and a solid financing facility.

Helios Energy has restarted production at its Texas Presidio wells and identified new drilling targets, setting the stage for a dual-track development strategy that balances early cashflow with longer-term growth.

Galilee Energy reported steady cash reserves and ongoing reservoir pressure monitoring at its Glenaras Gas Project, while exploring new funding and growth opportunities.

Bowen Coking Coal Ltd has released its updated 2025 Coal Resources and Reserves statement, reflecting mining depletion and joint venture ownership changes amid ongoing administration. The report details nuanced shifts across key Queensland projects, underscoring operational challenges and asset continuity.

Imugene Limited reports an 81% overall response rate in its azer-cel CAR T-cell therapy trial for difficult lymphomas, alongside a $25 million capital raise that extends its cash runway to mid-2027.

Uscom Limited reported a 27% drop in cash reserves for Q1 2025, driven by declining revenue and rising costs, while preparing to sell its main business unit to stabilize finances.